Skip to main content
Avivagen Inc. logo

Avivagen Inc. — Investor Relations & Filings

Ticker · VIV ISIN · CA05382F2026 TSXV Manufacturing
Open in API
Filings indexed 552 across all filing types
Latest filing 2023-02-06 Regulatory Filings
Country CA Canada
Listing TSXV VIV

About Avivagen Inc.

http://www.avivagen.com

Avivagen Inc. was a life sciences corporation focused on developing and commercializing natural health products for livestock, companion animals, and humans. The company specialized in feed additives designed to support immune function and promote growth in animals, emphasizing science-based validation through clinical trials. On April 23, 2024, Avivagen Inc. filed a voluntary assignment in bankruptcy, and a trustee was appointed to manage the proceedings.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings
2023-02-06 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing the publication of a peer-reviewed scientific paper about Avivagen's OxC-beta™ product. It highlights the scientific and commercial evidence presented in the paper, including research trials and regulatory approvals. The document does not contain financial statements, regulatory filings, or detailed financial data. It is not an annual report, interim report, earnings release, or any other formal financial or regulatory filing. It is also not a presentation, call transcript, or management report. The document serves as a public announcement of the publication of a scientific report, which is external to the company and linked to a journal. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories.
2023-01-19 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Avivagen Inc. has entered into securities for services agreements with its CEO and CSO, allowing the company to settle part of their fees or salary in common shares. The text details the terms of these agreements, including the maximum value of shares to be issued and the pricing method. There is no financial report, earnings data, or detailed financial statements included. The document is an announcement about a capital-related agreement involving share issuance for services, which fits the category of Capital/Financing Update (CAP). The document length is 5886 characters, which is sufficient for a substantive announcement rather than a brief notice. Therefore, the appropriate classification is CAP with high confidence.
2022-12-22 English
Material change report - English.pdf
Capital/Financing Update Classification · 100% confidence The document is titled 'FORM 51-102F3 Material Change Report' and details a material change event related to the closing of a private placement financing by Avivagen Inc. It includes specifics about the offering, proceeds, and related fees. The document is a regulatory filing form used in Canadian securities regulation to report material changes. It is not a full financial report, earnings release, or management discussion but a formal notification of a material event. The content aligns with a Capital/Financing Update as it reports on fundraising activity and capital structure changes. The document length (7290 characters) supports it being a full report rather than a brief announcement. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-11-14 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of the second tranche of a private placement of shares by Avivagen Inc. It details the number of shares issued, the gross proceeds, the finder's fees, and the intended use of the proceeds. There is no financial statement or detailed financial report included. The content focuses on financing activities and capital raising. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is over 6,000 characters, indicating it is not a brief announcement of a report publication or a regulatory filing. Hence, the classification is CAP with high confidence.
2022-10-31 English
News release - English.pdf
Regulatory Filings
2022-10-22 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.